1-6 of 6
Neng Yu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Allogeneic Stem Cell Transplant (Allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) in Patients Older Than 75 Years: A Single Center Analysis

Rajneesh Nath, MD, Jan Cerny, MD PhD, Muthalagu Ramanathan, MD, Zheng Zhou, MD PhD, Neng Yu, MD, Glen D Raffel, MD PhD, Jayde Bednarik, PharmD
Journal: Blood
Blood (2016) 128 (22): 5875.
https://doi.org/10.1182/blood.V128.22.5875.5875
Published: 2016
Journal Articles

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

Craig Kollman, Stephen R. Spellman, Mei-Jie Zhang, Anna Hassebroek, Claudio Anasetti, Joseph H. Antin, Richard E. Champlin, Dennis L. Confer, John F. DiPersio, Marcelo Fernandez-Viña, Robert J. Hartzman, Mary M. Horowitz, Carolyn K. Hurley, Chatchada Karanes, Martin Maiers, Carlheinz R. Mueller, Miguel-Angel Perales, Michelle Setterholm, Ann E. Woolfrey, Neng Yu, Mary Eapen
Journal: Blood
Blood (2016) 127 (2): 260–267.
https://doi.org/10.1182/blood-2015-08-663823
Published: 2016
Journal Articles

Unrelated Donor (UD) Cord Blood (CB) Stem Cell Transplantation (SCT) from a Single CB Unit in Older Adults: Excellent Engraftment and Low Early Mortality with a Preparative Regimen of Melphalan (M), Thiotepa (T), Fludarabine(F), and Rabbit (r) Anti Thymocyte Globulin (ATG)

Rajneesh Nath, MD, Muthalagu Ramanathan, MD, Jan Cerny, MD PhD, Zheng Zhou, MD PhD, Glen D Raffel, MD PhD, Jayde Bednarik, Pharm D, Neng Yu, MD, Laura J Petrillo-Deluca, PA-C, Zeina Al-Mansour, MD, Zankar Desai
Journal: Blood
Blood (2014) 124 (21): 1152.
https://doi.org/10.1182/blood.V124.21.1152.1152
Published: 2014
Journal Articles

High Dose Cyclophosphamide (HDCy) Post Stem Cell Transplant (SCT) Following High Dose Melphalan (HDMel) Based Conditioning As a Dual Strategy For Chemotherapy Dose Intensity and Graft Versus Host Disease (gvhd) Prophylaxis In Matched and Mismatched allogeneic (allo) SCT

Rajneesh Nath, MD, Jan Cerny, MD, Ph.D, Muthalagu Ramanathan, MD, Glen D Raffel, M.D, Ph.D., Jayde Bednarik, Pharm D, Neng Yu, MD, Zankar Desai, Lindsey Shanahan, PA-C, Natasha Fortier, PA-C, Mridula George, MD, Aimee Kroll-Desrosiers, MS
Journal: Blood
Blood (2013) 122 (21): 4554.
https://doi.org/10.1182/blood.V122.21.4554.4554
Published: 2013
Journal Articles

Donor KIR3DL1 and HLA-B Allotypes Control Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Fabio Giglio, MD, Ted A. Gooley, PhD, Jeffrey M Venstrom, MD, Meighan M Gallagher, LiHua Hou, PhD, Carolyn K Hurley, PhD, Tatiana Lebedeva, MD, PhD, Harriet Noreen, CHS, Raja Rajalingam, PhD, Elaine F Reed, PhD, Neng Yu, MD, Cynthia Vierra-Green, MS, Michael D Haagenson, MS, Mari Malkki, PhD, Effie W. Petersdorf, MD, Stephen Spellman, MBS, Katharine C. Hsu, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 349.
https://doi.org/10.1182/blood.V120.21.349.349
Published: 2012
Journal Articles

Allogeneic NK Cell Therapy After Autologous Stem Cell Transplant: Results of a Phase I Study

Hans-Georg Klingemann, MD, PhD, Carrie Grodman, RN, Andreas K. Klein, MD, Kellie Sprague, MD, Kenneth B. Miller, MD, Tarun Kewalramani, MD, Raymond L. Comenzo, MD, Neng Yu, MD, Marvin Duque, MD, Richard A. Van Etten, MD, PhD, David McKenna, MD
Journal: Blood
Blood (2010) 116 (21): 4299.
https://doi.org/10.1182/blood.V116.21.4299.4299
Published: 2010